INNOVADERM CRO IS NOW INDERO.
READ THE ANNOUNCEMENT
Talk to us

Topic: Technology, AI & Data

Next-Gen Drug Development: The AI Advantage

artificial intelligence in drug development

In this article, we explore the transformative impact of Artificial Intelligence (AI) on drug development and clinical trials. We had the opportunity to speak with three distinguished experts in the field: Guillaume Gigon, Vice President of Technology and AI at Indero; Nardin Nakhla, Co-Founder and CTO of Simmunome; and Christian Dansereau, Founder and CEO of […]

Leveraging Technology in Phase I Clinical Trials

This white paper is a must-read for anyone involved in clinical research. Whether you’re a seasoned professional or new to the field, the insights provided will enhance your understanding and approach to Phase I studies.

Talk to us

Jeff Smith

Chef de la direction
Linkedin

Jeff Smith, Chef de la direction d’Indero Recherches, apporte prĂšs de 30 ans d’expĂ©rience dans l’industrie pharmaceutique et CRO, s’Ă©tant distinguĂ© par son leadership exceptionnel, sa vision stratĂ©gique et son innovation. L’expertise de Jeff couvre des opĂ©rations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matiĂšre de crĂ©ation de valeur, de gestion des partenaires et d’opĂ©rations CRO ont toujours contribuĂ© au succĂšs dans ses fonctions prĂ©cĂ©dentes. Sous la direction de Jeff, Indero continue d’étendre ses capacitĂ©s, faisant progresser les connaissances mĂ©dicales et les nouvelles thĂ©rapies en dermatologie et en rhumatologie.